Dallas, TX
Joined August 2026
Plano Company @ActinideInc creates breakthrough particle accelerator that produces material crucial to prostate cancer drug, Pluvicto. It also can be reconfigured to enrich uranium. CEO @EricOlsz says this can reduce American 🇺🇸 Dependence on Russia for critical materials @FOX4
8
7
3
46
6,050
David retweeted
We’re back. On today's show: - @jordanschneider (ChinaTalk) - @stephenbalaban (Lambda) - @EricOlsz (Actinide) - @atomicallypure (Actinide) - @billythalheimer (Regent) - @AaronLCannon (Outset AI) See you on the stream.
6
7
3
56
38,169
David retweeted
Replying to @CJHandmer
True
140
68
13
1,726
72,681
In just a few weeks, we succeeded in producing HALEU - a critical material with a multi-year waitlist. The recovered HALEU was produced in research quantities under the laboratory-scale exclusion in NRC regulations and was verified to be 15.38% enriched by an independent ISO/IEC 17025-accredited lab - well within the 5-20% qualifier for HALEU.
2
23
1
549
35,931
This week, @ActinideInc became the first startup in history to enrich uranium, producing HALEU, the fuel for next-gen and small modular reactors. We did it using Endurance, a particle accelerator that we designed and built in Texas. Endurance usually produces enriched Yb-176, a precursor for cancer therapies worth roughly $30,000 per gram. After a bulk Yb-176 delivery on July 30, we reconfigured Endurance for uranium.
276
497
271
4,587
1,152,298